+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Buccal Drug Delivery Systems Market - Global Forecast to 2030- Product Image
Buccal Drug Delivery Systems Market - Global Forecast to 2030- Product Image
Sale

Buccal Drug Delivery Systems Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011476
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Buccal Drug Delivery Systems Market grew from USD 2.43 billion in 2024 to USD 2.67 billion in 2025. It is expected to continue growing at a CAGR of 9.44%, reaching USD 4.18 billion by 2030.

Buccal drug delivery systems have emerged as a vital innovation in pharmaceutical development, offering a non-invasive route of administration that enhances patient compliance and therapeutic efficacy. By bypassing the gastrointestinal tract and first-pass hepatic metabolism, medications delivered through the buccal mucosa can achieve rapid onset of action and improved bioavailability. This introduction outlines the fundamentals of buccal delivery, its clinical advantages, and the evolving landscape of formulations-ranging from films and lozenges to sublingual sprays and tablets. Recent advances in mucoadhesive polymers and nanocarrier technologies have further propelled the field, enabling targeted release profiles and sustained therapeutic levels.

As healthcare providers and industry stakeholders seek alternatives to oral and injectable routes, buccal systems offer a compelling solution for managing pain, hormonal disorders, infectious diseases, and more. This section establishes the context for understanding how formulation innovations, material science breakthroughs, and regulatory frameworks converge to shape a rapidly evolving market. It also highlights the interplay between academic research, biotechnology companies, and clinical practice in driving adoption of buccal platforms. Readers will gain foundational knowledge that sets the stage for deeper insights into transformative trends, regulatory impacts, segmentation data, regional dynamics, and strategic recommendations presented in the following sections.

Transformative Shifts in Buccal Delivery Innovation

The buccal delivery landscape is undergoing transformative shifts fueled by breakthroughs in material engineering, personalized medicine, and digital health integration. Advanced mucoadhesive polymers have unlocked new possibilities for controlled release of small molecule drugs, biologics, and novel therapeutic modalities. Concurrently, innovations in micro- and nanoparticle technologies are enabling precise dosing and enhanced mucosal penetration, leading to improved therapeutic outcomes.

Digital health platforms are complementing these advances by facilitating remote monitoring of adherence and pharmacokinetic profiles, thereby closing the loop between patient behavior and clinical decision-making. The convergence of freeze-drying, hot-melt extrusion, and solvent casting manufacturing processes is accelerating scale-up of complex formulations, while spray-drying techniques support development of stable microparticulate systems. Furthermore, the rise of vaccines and biologics delivered via the buccal route has opened new avenues for immunization without needles, enhancing patient acceptance.

Taken together, these shifts underscore a market transformation driven by interdisciplinary collaboration among pharmaceutical scientists, engineers, and healthcare professionals. The resulting ecosystem is more agile, data-driven, and patient-centric, setting the stage for next-generation buccal therapeutics.

Cumulative Impact of U.S. Tariffs in 2025

In 2025, newly implemented United States tariffs have introduced significant cost pressures across the supply chain for raw materials and excipients used in buccal formulations. Increased duties on polymers-both natural and synthetic-have driven material costs upward, impacting manufacturers reliant on hydrogel matrices and mucoadhesive components. Tariffs affecting specialized equipment for solvent casting and spray-drying have also raised capital expenditure requirements, delaying investment in capacity expansions.

These regulatory changes have prompted a strategic pivot toward onshore sourcing of critical inputs and acceleration of partnerships with domestic suppliers. Companies are reevaluating formulation compositions to incorporate more readily available biopolymers and exploring alternative manufacturing techniques that mitigate tariff-related expenses. Additionally, long-term contracts and hedging strategies are being deployed to stabilize pricing volatility.

Despite the cost headwinds, some players are leveraging these challenges as catalysts for innovation-optimizing processing workflows and adopting modular manufacturing lines to enhance efficiency. The net effect is a reshaped landscape in which resilience, supply chain diversification, and agile process development have become key competitive differentiators.

Key Segmentation Insights Across Multiple Dimensions

A holistic analysis of buccal drug delivery reveals distinct dynamics across multiple segmentation dimensions. By technology type, developers are balancing liquid formulations and matrix devices against emerging micro- and nanoparticle strategies, while integrating mucoadhesive polymers and reservoir devices to fine-tune release characteristics. Within drug type, the sector spans small molecule drugs, biologics, and novel therapeutics, each presenting unique formulation and regulatory challenges.

Applications range from pain management and hormonal treatments to cancer therapy and infectious disease interventions, as well as niche areas such as oral hygiene. End-user profiles cover academic and research institutes advancing early-stage platforms, homecare settings adopting user-friendly designs, hospitals and clinics prioritizing rapid on-site administration, and pharmaceutical and biotechnology companies driving commercialization.

Patient demographics also shape product design-formulations tailored for pediatric, adult, chronic patient, elderly, and pregnant women segments must account for varying mucosal permeability and dose requirements. Dissolution rate considerations span immediate, controlled, and modified release profiles, while formulation types include films, lozenges, sublingual sprays, and tablets. Both buccal and sublingual administration routes are being optimized, employing hydrogels, natural polymers, and synthetic polymers as base materials. Finally, manufacturing processes such as freeze-drying, hot-melt extrusion, solvent casting, and spray-drying are selected to meet scalability, stability, and cost targets.

Key Regional Insights Shaping Market Dynamics

Regional insights reveal diverging adoption patterns and growth drivers across established and emerging markets. In the Americas, robust intellectual property protections and advanced healthcare infrastructure support rapid uptake of sophisticated buccal systems, with the United States leading in R&D investment, regulatory approvals, and clinical trials. Canada and Latin America present opportunities in chronic disease management, leveraging patient preference for non-invasive therapies.

Europe, Middle East & Africa exhibit heterogeneous dynamics: Western Europe demonstrates strong collaboration between academia and industry, driving innovation in mucoadhesive technologies, while emerging markets in Eastern Europe and the Middle East focus on improving access to affordable pain management and hormonal treatments via generic buccal platforms. Africa’s nascent biopharma sector is gradually exploring vaccine delivery through mucosal routes.

Asia-Pacific remains a high-potential region, with accelerating investments in manufacturing capacity, particularly in China and India. Regulatory harmonization efforts are streamlining approvals for buccal dosage forms, and increasing healthcare expenditure is fueling demand for novel therapeutics in oncology, infectious diseases, and diabetes management.

Key Companies Driving Innovation and Collaboration

Leading companies in the buccal delivery space span global pharmaceutical giants, specialized innovators, and contract development organizations. Multinational corporations such as Pfizer Inc., Novartis AG, and AstraZeneca Plc are leveraging their formulation expertise and global distribution networks to advance mucoadhesive films and sublingual sprays. Biotechnology-focused firms including Amgen Inc., Novo Nordisk A/S, and Nektar Therapeutics are exploring peptide and protein delivery via the buccal mucosa.

Specialized players such as Aquestive Therapeutics, Inc., and Camurus are pioneering novel matrix devices and reservoir systems, while Catalent, Inc., DuPont de Nemours, Inc., and Tesa Labtec GmbH provide end-to-end services in process development and scale-up. Companies like Cure Pharmaceutical and Vectura Group are harnessing advanced carrier technologies to enhance mucosal penetration, and ARx, LLC, Generex Biotechnology, and Herantis Pharma PLC focus on niche applications including vaccine administration.

Smaller innovators such as LTS Lohmann Therapie-Systeme AG, MedLab Clinical Ltd, Sorrento Therapeutics, Inc., and 3M Company contribute modular manufacturing solutions and proprietary polymers. Indivior PLC and Camurus drive growth in pain management segments, while broader pharma groups integrate buccal platforms into their portfolios. This competitive landscape underscores the importance of strategic alliances, intellectual property management, and targeted R&D investments.

Actionable Recommendations for Industry Leaders

Industry leaders must adopt a multifaceted strategy to capitalize on the buccal delivery opportunity. First, conducting robust cross-functional collaboration between formulation scientists, process engineers, and clinical teams will accelerate development timelines and mitigate technical risks. Integrating real-world patient feedback into early design phases ensures that user experience and adherence considerations inform material selection and device ergonomics.

Second, establishing strategic partnerships with domestic and international suppliers can alleviate tariff-induced cost pressures. Long-term agreements and joint ventures will secure supply chain resilience for critical polymers and specialized excipients. Concurrently, investing in modular, scalable manufacturing platforms-such as hot-melt extrusion coupled with spray-drying modules-enables rapid pivoting across multiple dosage forms.

Third, leveraging data analytics and digital health tools to monitor patient adherence and pharmacokinetic profiles provides actionable insights for iterative formulation optimization. Real-time data exchange with regulatory authorities can streamline submission processes and support adaptive trial designs. Finally, cultivating targeted collaborations with academic centers and contract research organizations accelerates early-stage innovation while sharing development risk.

Conclusion and Outlook for Buccal Platforms

Buccal drug delivery systems represent a compelling pathway to enhance therapeutic efficacy, improve patient compliance, and diversify administration routes. The intersection of advanced materials science, precision manufacturing, and digital health integration is driving the evolution from conventional oral dosage forms to sophisticated mucosal platforms. Despite emerging cost challenges from tariff adjustments and supply chain complexities, resilient strategies centered on onshore sourcing, modular manufacturing, and data-driven development are positioning market participants for sustained success.

As the field matures, collaboration across industry stakeholders-from global pharmaceutical companies to niche innovators and academic research hubs-will be crucial for overcoming technical and regulatory hurdles. By prioritizing patient-centric design, streamlined process workflows, and strategic alliances, organizations can unlock the full potential of buccal delivery technologies. The insights presented herein equip decision-makers with a clear understanding of current trends, segmentation dynamics, and region-specific nuances that will shape the future of non-invasive drug administration.

Market Segmentation & Coverage

This research report categorizes the Buccal Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Liquid Formulations
  • Matrix Devices
  • Micro/Nanoparticles
  • Mucoadhesive Polymers
  • Reservoir Devices
  • Vaccines
  • Biologics
  • Novel Therapeutics
  • Small Molecule Drugs
  • Cancer Therapy
  • Hormonal Treatments
  • Infectious Diseases
  • Oral Hygiene
  • Pain Management
  • Academic And Research Institutes
  • Homecare Settings
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Adults
  • Chronic Patients
  • Elderly
  • Pediatric
  • Pregnant Women
  • Controlled Release
  • Immediate Release
  • Modified Release
  • Films
  • Lozenges
  • Sublingual Sprays
  • Tablets
  • Buccal
  • Sublingual
  • Hydrogels
  • Natural Polymers
  • Synthetic Polymers
  • Freeze Drying
  • Hot-Melt Extrusion
  • Solvent Casting Method
  • Spray Drying

This research report categorizes the Buccal Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Buccal Drug Delivery Systems Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 3M Company
  • Amgen Inc.
  • Aquestive Therapeutics, Inc.
  • ARx, LLC
  • AstraZeneca Plc
  • Camurus
  • Catalent, Inc.
  • Cure Pharmaceutical
  • DuPont de Nemours, Inc.
  • Generex Biotechnology
  • Herantis Pharma PLC
  • Indivior PLC
  • LTS Lohmann Therapie-Systeme AG
  • MedLab Clinical Ltd
  • Nektar Therapeutics
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sorrento Therapeutics, Inc.
  • Tesa Labtec GmbH
  • Vectura Group

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Buccal Drug Delivery Systems Market, by Technology Type
8.1. Introduction
8.2. Liquid Formulations
8.3. Matrix Devices
8.4. Micro/Nanoparticles
8.5. Mucoadhesive Polymers
8.6. Reservoir Devices
8.7. Vaccines
9. Buccal Drug Delivery Systems Market, by Drug Type
9.1. Introduction
9.2. Biologics
9.3. Novel Therapeutics
9.4. Small Molecule Drugs
10. Buccal Drug Delivery Systems Market, by Application
10.1. Introduction
10.2. Cancer Therapy
10.3. Hormonal Treatments
10.4. Infectious Diseases
10.5. Oral Hygiene
10.6. Pain Management
11. Buccal Drug Delivery Systems Market, by End-User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Homecare Settings
11.4. Hospitals And Clinics
11.5. Pharmaceutical And Biotechnology Companies
12. Buccal Drug Delivery Systems Market, by Patient Demographics
12.1. Introduction
12.2. Adults
12.3. Chronic Patients
12.4. Elderly
12.5. Pediatric
12.6. Pregnant Women
13. Buccal Drug Delivery Systems Market, by Dissolution Rate
13.1. Introduction
13.2. Controlled Release
13.3. Immediate Release
13.4. Modified Release
14. Buccal Drug Delivery Systems Market, by Formulation Type
14.1. Introduction
14.2. Films
14.3. Lozenges
14.4. Sublingual Sprays
14.5. Tablets
15. Buccal Drug Delivery Systems Market, by Route of Administration
15.1. Introduction
15.2. Buccal
15.3. Sublingual
16. Buccal Drug Delivery Systems Market, by Material Used
16.1. Introduction
16.2. Hydrogels
16.3. Natural Polymers
16.4. Synthetic Polymers
17. Buccal Drug Delivery Systems Market, by Manufacturing Process
17.1. Introduction
17.2. Freeze Drying
17.3. Hot-Melt Extrusion
17.4. Solvent Casting Method
17.5. Spray Drying
18. Americas Buccal Drug Delivery Systems Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Buccal Drug Delivery Systems Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Buccal Drug Delivery Systems Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. 3M Company
21.3.2. Amgen Inc.
21.3.3. Aquestive Therapeutics, Inc.
21.3.4. ARx, LLC
21.3.5. AstraZeneca Plc
21.3.6. Camurus
21.3.7. Catalent, Inc.
21.3.8. Cure Pharmaceutical
21.3.9. DuPont de Nemours, Inc.
21.3.10. Generex Biotechnology
21.3.11. Herantis Pharma PLC
21.3.12. Indivior PLC
21.3.13. LTS Lohmann Therapie-Systeme AG
21.3.14. MedLab Clinical Ltd
21.3.15. Nektar Therapeutics
21.3.16. Novartis AG
21.3.17. Novo Nordisk A/S
21.3.18. Pfizer Inc.
21.3.19. Sorrento Therapeutics, Inc.
21.3.20. Tesa Labtec GmbH
21.3.21. Vectura Group
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. BUCCAL DRUG DELIVERY SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. BUCCAL DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. BUCCAL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. BUCCAL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATRIX DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRO/NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MUCOADHESIVE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESERVOIR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NOVEL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL HYGIENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CHRONIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PREGNANT WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODIFIED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBLINGUAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BUCCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FREEZE DRYING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOT-MELT EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLVENT CASTING METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAY DRYING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 86. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 91. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 92. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 93. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 95. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 138. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 139. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 143. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 144. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 147. CHINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 148. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 149. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 153. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 154. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 155. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 157. INDIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 168. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 169. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 170. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 173. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 174. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 175. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 203. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 213. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 214. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 220. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 223. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 224. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 228. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 229. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 230. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 233. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 234. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 235. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 237. THAILAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 240. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 243. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 244. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 245. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 247. VIETNAM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 259. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 260. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 261. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 264. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 265. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 268. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 269. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 270. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 274. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 275. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 276. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 278. EGYPT BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 279. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 280. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 284. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 285. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 289. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 290. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 291. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 294. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 295. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 296. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL USED, 2018-2030 (USD MILLION)
TABLE 298. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 299. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 300. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 301. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 304. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLUTION RATE, 2018-2030 (USD MILLION)
TABLE 305. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 306. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. GERMANY BUCCAL DRUG DELIVERY SYS

Companies Mentioned

  • 3M Company
  • Amgen Inc.
  • Aquestive Therapeutics, Inc.
  • ARx, LLC
  • AstraZeneca Plc
  • Camurus
  • Catalent, Inc.
  • Cure Pharmaceutical
  • DuPont de Nemours, Inc.
  • Generex Biotechnology
  • Herantis Pharma PLC
  • Indivior PLC
  • LTS Lohmann Therapie-Systeme AG
  • MedLab Clinical Ltd
  • Nektar Therapeutics
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sorrento Therapeutics, Inc.
  • Tesa Labtec GmbH
  • Vectura Group

Methodology

Loading
LOADING...

Related Topics

Related Reports

Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges), By Application (Pain Management, Smoking Cessation, Angina Pectoris), By End-use, By Region, And Segment Forecast, 2024 - 2030 - Product Image

Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges), By Application (Pain Management, Smoking Cessation, Angina Pectoris), By End-use, By Region, And Segment Forecast, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 257 Pages
  • Global
From
Buccal Drug Delivery Systems - Global Strategic Business Report - Product Image

Buccal Drug Delivery Systems - Global Strategic Business Report

  • Report
  • 368 Pages
  • Global
From
Buccal Drug Delivery System Market Report 2025 - Product Image

Buccal Drug Delivery System Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Buccal Drug Delivery System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Buccal Drug Delivery System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From

About the Buccal Drug Market

The Buccal Drug Delivery market is a subset of Transdermal and Transmucosal Drug Delivery, which refers to the administration of drugs through the skin or mucous membranes. Buccal Drug Delivery involves the administration of drugs through the buccal mucosa, which is the mucous membrane lining the inside of the cheeks. This method of drug delivery is advantageous because it is non-invasive, has a rapid onset of action, and is suitable for both local and systemic drug delivery. It is also advantageous for drugs that are not suitable for other routes of administration, such as those that are rapidly metabolized in the gastrointestinal tract. Some companies in the Buccal Drug Delivery market include 3M Drug Delivery Systems, Aquestive Therapeutics, Inc., and Zosano Pharma Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.